Lupus (SLE) trials in India

3 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  Rollover Study for Participants Who Have Completed a Previous Clinical Study With Anifrolumab (Saphnelo) and Clinically Benefited From Continued Treatment

  Where

  Hyderabad, Kolkata, New Delhi, Pune

  Age

  5 years to 80 years

  People

  1,072 worldwide

  Run by

  AstraZeneca

  See details and how to joinNCT07691970
• Phase 3Taking people
  Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).

  Where

  Ahmedabad, Dehradun, Kolhāpur, Kozhikode, Nagpur, Nashik, New Delhi, Pune

  Age

  12 years to 100 years

  People

  550 worldwide

  Run by

  Novartis Pharmaceuticals

  See details and how to joinNCT06133972 · EU 2023-505929-14-00
• Phase 2Taking people
  A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE)

  Where

  Kochi, Kolkata, Maharashtra, New Delhi

  Age

  18 years to 74 years

  People

  405 worldwide

  Run by

  Boehringer Ingelheim

  See details and how to joinNCT07409181 · EU 2025-523488-39-00